PT - JOURNAL ARTICLE AU - Rudolf Markt AU - Markus Mayr AU - Evelyn Peer AU - Andreas O. Wagner AU - Nina Lackner AU - Heribert Insam TI - Detection and stability of SARS-CoV-2 fragments in wastewater: Impact of storage temperature AID - 10.1101/2021.02.22.21250768 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.22.21250768 4099 - http://medrxiv.org/content/early/2021/02/25/2021.02.22.21250768.short 4100 - http://medrxiv.org/content/early/2021/02/25/2021.02.22.21250768.full AB - SARS-CoV-2 wastewater epidemiology suffers from uncertainties concerning sample storage. We show the effect of storage of wastewater on the detectable SARS-CoV-2 load. Storage at 4 °C up to 9 days had no significant effect, while storage at −20 °C led to a significant reduction in gene copy numbers.HighlightsRaw wastewater samples can be stored up to 9 days at 4°C for SARS-CoV-2 wastewater surveillanceFreezing of wastewater sample dramatically decreases RT-qPCR signal of SARS-CoV-2 from wastewater.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialFor this study enviromental samples where taken, therefore no trial ID was necessary.Funding StatementThis work was financially supported by the Foerderkreis 1669 - Wissenschaft Gesellschaft and by the Austrian Federal Ministry of Education, Science and Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight body approval was needed for the present study,as we worked with enviromental, not personalised data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this published article.